Home>Topics>Drug Companies

Drug Companies

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Morningstar's Most Popular

    Headlines

    Fri, 22 May 2015

    Mobil AT&T Most Requested Stock Analyses SandRidge Energy Peabody Energy Spectra Energy Berkshire Hathaway Lexicon Pharmaceuticals Most Requested Fund Quotes Vanguard Dividend Growth Vanguard 500 Index Fidelity Contrafund Fidelity Select Biotechnology

  2. CVS Acquires Omnicare, Enhancing Mail-Order and PBM Assets

    Commentary

    Thu, 21 May 2015

    On May 21, CVS Health announced the acquisition of Omnicare, a major distributor/wholesaler of pharmaceuticals to long-term care facilities, for $98 per share, or for approximately $12.7 billion. While we are still analyzing the

  3. LPC-Endo reveals $9.275 bln loan package for Par buy

    Headlines

    Thu, 21 May 2015

    LONDON, May 21 (Reuters) - Specialty drugmaker Endo International has agreed a $9.275 billion loan package backing its $8.05 billion acquisition of privately-owned Par Pharmaceuticals , the borrower announced in an SEC filing on Thursday.

  4. BRIEF-Veloxis Pharmaceuticals Q1 operating loss widens to DKK 46.5 mln

    Headlines

    Thu, 21 May 2015

    * Reported on Wednesday Q1 revenue of 4.3 million Danish crowns ($641,503.80) versus 12.2 million crowns year ago

  5. Friday Five: Fed Takes the Market's Hand

    Video Reports

    Thu, 21 May 2015

    very important for PBMs. They have to negotiate with the drug companies , and the more patients they represent, the more discounts ..... negotiate, and the more clout they will have with those drug companies . That helps bring down costs and improve profitability

    Drug Companies found at 3:08

    scale is very important for PBMs. They have to negotiate with the drug companies , and the more patients they represent, the more discounts they are going to be able to negotiate, and the more clout they will have with those drug companies . That helps bring down costs and improve profitability for these PBMs. Now, we still think that [TICKER:ESRX] Express Scripts is the best buy
  6. CORRECTED-UPDATE 1-Achillion partners with J&J to develop hep C drugs (May 19)

    Headlines

    Wed, 20 May 2015

    May 19 (Reuters) - Achillion Pharmaceuticals Inc said it will collaborate with Johnson & Johnson to develop and market its hepatitis C drugs including an oral regimen that could work on all genotypes and shorten treatment time.

  7. Valeant in talks to buy Egyptian drugmaker Amoun Pharma-Bloomberg

    Headlines

    Wed, 20 May 2015

    May 20 (Reuters) - Valeant Pharmaceuticals International Inc is in talks to buy Egyptian drugmaker Amoun Pharmaceutical Co to expand its veterinary and human medicines portfolio, Bloomberg reported, citing people familiar with the matter.

  8. UPDATE 1-Achillion partners with J&J to develop hep C drugs

    Headlines

    Tue, 19 May 2015

    May 19 (Reuters) - Achillion Pharmaceuticals Inc said it will collaborate with Johnson & Johnson to develop and market its hepatitis C drugs including an oral regimen that could work on all genotypes and shorten treatment time.

  9. Achillion partners with J&J to develop hep C drugs

    Headlines

    Tue, 19 May 2015

    May 19 (Reuters) - Achillion Pharmaceuticals Inc said it will collaborate with Johnson & Johnson to develop and market one or more of its hepatitis C drugs.

  10. Valeant CEO expects sharp rise in Asia revenue by 2020

    Headlines

    Tue, 19 May 2015

    MONTREAL, May 19 (Reuters) - Valeant Pharmaceuticals International Inc's exposure to Asia's growing middle class could help lead to the quintupling of sales in that market to around $5 billion by...

« Prev12345Next »
Content Partners